-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $110

Benzinga·04/27/2026 14:57:02
Listen to the news
Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $104 to $110.